total
| No | title | Writer | Date | Hit |
|---|---|---|---|---|
| 12 | Recombinant virus development and safety management( lecture material) | 관리자 | Date22.08.16 | Hit218 |
| 11 | Market for viral vector manufacturing, 2018 | 관리자 | Date22.08.16 | Hit227 |
| 10 | Characterizing Accidents, Exposures, and Laboratory-acquired Infections Reported to the National Institutes of Health’s Office of Biotechnology Activities (NIH/OBA) Div… | 관리자 | Date22.08.16 | Hit212 |
| 9 | Recombinant protein production and transfected cell line bank establishment | 관리자 | Date20.04.16 | Hit472 |
| 8 | WHO guidelines on nonclinical evaluation of vaccines II | 관리자 | Date20.03.11 | Hit447 |
| 7 | Next generation of Whole cell Pneumococua vaccine | 관리자 | Date20.03.11 | Hit432 |
| 6 | Development_of_the_Sanofi_Pasteur_tetravalent_deng (1) | 관리자 | Date20.03.11 | Hit451 |
| 5 | Safety Pharmacology Evaluation of Biopharmaceuticals | 관리자 | Date20.03.09 | Hit395 |
| 4 | Preclinical Assessment of Investigational Cellular and Gene Therapy Products | 관리자 | Date20.03.09 | Hit382 |
| 3 | ICH Considerations Oncolytic Viruses | 관리자 | Date20.03.09 | Hit431 |